I take your point. Unfortunately, I am not very good at detailed balance sheet analysis.
I have seen related party loans in micro/small caps a very common thing.
I generally ignore it if it is not large enough.
For example you can read NGL Fine Chem AR. There are quite a few RPTs. Still a great value creator the stock has been and I would rate management as A+.
Regards,
Raj
Disc: Invested. No trading in last one year.
Subscribe To Our Free Newsletter |